We previously have reported that ApoG2 is a promising compound that kills nasopharyngeal carcinoma (NPC) cells by inhibiting the antiapoptotic function of Bcl-2 proteins. The gene discussed is BCL2; the disease is nasopharyngeal carcinoma.